[ad_1]
POINT Biopharma Global PNT reported its Q2 earnings results on Friday, August 12, 2022 at 08:30 AM.
Here’s what investors need to know about the announcement.
Earnings
POINT Biopharma Global missed estimated earnings by 22.73%, reporting an EPS of $-0.27 versus an estimate of $-0.22.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 3.02% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for POINT Biopharma Global visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.